Merve Gözde SEZGİN
(Akdeniz Üniversitesi Hastanesi, Antalya, Türkiye)
HİCRAN BEKTAŞ
(Akdeniz Üniversitesi, Hemşirelik Fakültesi, İç Hastalıkları Hemşireliği Anabilim Dalı, Antalya, Türkiye)
Yıl: 2020Cilt: 28Sayı: 2ISSN: 2147-4923 / 2687-6442Sayfa Aralığı: 143 - 154İngilizce

43 0
Symptom Clustering and Its Effect on Functional Status in Lymphoma Patients
Aim: The study aimed to determine the effect of symptom clustering and its effect on functional status in patients with lymphoma. Method: This descriptive study was conducted with 109 patients with lymphoma in the Hematology Clinic, Hematology Outpatient Clinic, and Chemotherapy Day Unit of a university hospital. Personal information form, Memorial Symptom Assessment Scale to assess symptoms, and the Functional Assessment of Cancer Therapy-Lymphoma to assess functional status were used in data collection. Frequency, percentage, arithmetic mean, significance test of difference between two means, Mann-Whitney U test, one-way analysis of variance, Kruskal Wallis analysis of variance, Pearson’s correlation test, Cronbach’s alpha internal consistency test, and cluster analysis were used to evaluate the data. Results: According to the Memorial Symptom Assessment Scale, the most common psychological symptoms in these patients were sleep disturbance, feeling sad and worried; whereas, their physical symptoms were pain, nausea, and dry mouth. Based on the results of the Functional Assessment of Cancer Therapy-Lymphoma Scale, it was found that the functional lives of the patients were negatively affected due to pain, low energy, feeling sad, worrying about the deterioration of the condition, fatigue and pain in certain parts of the body. In the frequency and severity subscales of Memorial Symptom Assessment Scale, gastrointestinal system symptoms were collected more intensively in the first clusters. Physical and psychological symptoms were regularly distributed in the distress subscale. Conclusion: As the symptom frequency, severity and distress subscales of Memorial Symptom Assessment Scale increased in lymphoma patients, their functional status deteriorated.
DergiAraştırma MakalesiErişime Açık
  • Aktaş, A., Walsh, D., & Hu, B. (2014). Cancer symptom clusters: An exploratory analysis of eight statistical techniques. Brief Methodological Report, 48(6), 1254-1266. [Crossref]
  • Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017). Non-Hodgkin lymphoma. Lancet, 390(10091), 298-310. [Crossref]
  • Barsevick, A. M. (2007). The concept of symptom cluster. Seminar Oncology Nursing, 23(2), 89-98. [Crossref]
  • Bölükbaş, F., & Kutlutürkan, T. (2014). Symptoms and symptom clusters in non hodgkin’s lymphoma patients in Turkey. Asian Pacific Journal of Cancer Prevention, 15(17), 7153-7158. [Crossref]
  • Can, G. (2014). Oncology nursing. (pp.851-884). Istanbul, Turkey: Nobel Medical Bookstores.
  • Cella, D. F., Webster, K., & Cashy, K. (2005). Development of a measure of health related quality of life for non-Hodgkin’s lymphoma clinical research: The functional assessment of cancer therapy - lymphoma (FACT-Lym). Blood, 106(11), 750. [Crossref]
  • Chen, E., Nguyen, J., Khan, L., Zhang, L., Cramarossa, G., Tsao, M. et al. (2012). Symptom clusters in patients with advanced cancer: A reanalysis comparing different statistical methods. Journal of Pain and Symptom Management, 44(1), 23-32. [Crossref]
  • Dodd, M. J., Cho, M. H., Cooper, B. A., Petersen, J., Bank, K.A., Lee, K. A. et al. (2011). Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncology Nursing Forum, 38(1), 33-42.
  • Dodd, M. J., Miaskowski, C., & Paul S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465–470.
  • Dong, S. T., Butow, P. N., Costa, D. S. J., Lovell, M. R., & Aggar, M. (2014). Symptom clusters in patients with advanced cancer: A systematic review of observational studies. Journal of Pain and Symptom Management, 48(3), 411-450. [Crossref]
  • FACIT. (2020). FACIT: Questionnaires. Retrived from: https://www.facit.org/FACITOrg/Questionnaires
  • Hindistan, S., Çilingir, D., Nural, N., & Aktaş-Gürsoy, A. (2012). Applications of patients with hematological cancer towards the symptoms they experience due to chemotherapy. Gümüşhane University Journal of Health Sciences,1(3), 153-164.
  • Hlubocky, F.J., Webster, K., Cashy, J., Beaumont, J., & Cella, D. (2013). The development and validation of a measure of health-related quality of life for Non-Hodgkin’s Lymphoma: the functional assessment of cancer therapy—lymphoma (FACT-Lym). Hindawi Publishing Corporation Lymphoma, 2013, 1-9. [Crossref]
  • Hsu, H. T., Lin, K. C., Wu, L. M., Juan, C. H., Hou, M. F., Hwang, S. L., et al. (2017). Symptom cluster trajectories during chemotherapy in breast cancer outpatients. Journal of Pain and Symptom Management, 53(6), 1017-1025. [Crossref]
  • Ji, Y. B., Bo, C. L., Xue, X. J., Weng, E. M., Gao, G. C., Dai, B. B., et al. (2017). Association of inflammatory cytokines with the symptom cluster of pain, fatigue, depression, and sleep disturbance in Chinese patients with cancer. Journal of Pain and Symptom Management, 54(6), 843-852. [Crossref]
  • Karabulut, N., Erci, B., Özer, N., & Özdemir, S. (2010). Symptom clusters and experiences of patients with cancer. Journal of Advanced Nursing, 66(5), 1011-1021. [Crossref]
  • Kim, H., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005). Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing, 28(4), 270-282.
  • Kim, M., Kim, K., Lim, C., & Kim, J. (2018). Symptom clusters and quality of life according to the survivorship stage in ovarian cancer survivors. Western Journal of Nursing Research, 40(9), 1278–1300. [Crossref]
  • Kwekkeboom, K. L. (2016). Cancer symptom cluster management. Seminars in Oncology Nursing, 32(4), 373-382. [Crossref]
  • Manson, S. D. & Porter, C. (2011). Lymphomas. Yarbro, C. H., Wujcik, D., & Gobel, B. H. (Eds.), Cancer nursing principles and practice. (7th ed., pp.1458-1512). USA: Jones and Bartlett Publishers.
  • Molassiotis, A., Farrell, C., Bourne, K., Brearley, S.G., & Pilling, M. (2012). Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer. Journal of Pain and Symptom Management, 44(6), 810-822. [Crossref]
  • Oh, H., Seo, Y., Jeong, H., & Seo, W. (2012). The identification of multiple symptom clusters and their effects on functional performance in cancer patients. Journal of Clinical Nursing, 21(19), 2832-2842. [Crossref]
  • Pirri, C., Bayliss, E., Trotter, J., Olver, N. I., Katris, P., Drummond, P. et al. (2013). Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer, 21(3), 735-748. [Crossref]
  • Poon, M., Dennis, K., DeAngelis, C., Chung, H., Stinson, J., Zhang, L., et al. (2015). Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index—Emesis (FLIE) quality-of-life tool. Support Care Cancer, 23(9), 2589-2598. [Crossref]
  • Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevelance, characteristics and distress. European Journal Cancer, 30(9), 1326-1336. [Crossref]
  • Süren, M., Doğru, S., Önder, Y., Çeltek, N. Y., Okan, İ., Karaman, S., & Başol, N. (2015). The evaluation of the symptom clusters in patients with the diagnosis of terminal stage cancer. The Turkish Society of Algology, 27(1), 12-17. [Crossref]
  • Wang, J., Jacobs, S., Dewalt, D. A., Stern, E., Gross, H., & Hinds, P. (2018). A longitudinal study of PROMIS pediatric symptom clusters in children undergoing chemotherapy. Journal of Pain and Symptom Management, 55(2), 359-367. [Crossref]
  • Wong, M. L., Cooper, B. A., Paul, S. M., Levine, J. D., Conley, Y. P., Wright, F., et al. (2017). Differences in symptom clusters ıdentified using ratings of symptom occurrence vs. severity in lung cancer patients receiving chemotherapy. Journal of Pain and Symptom Management, 54(2), 194-203. [Crossref]
  • World Health Organization (2020). Canser Today-IARC. Retrived from: https://gco.iarc.fr/today/online-analysistable?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1.
  • Yıldırım, Y., Tokem, Y., Bozkurt, N., Fadıloğlu, Ç., Uyar, M., & Uslu, R. (2011). Reliability and validity of the Turkish version of Memorial Symptom Assessment Scale in cancer patients. Asian Pacific Journal of Cancer Prevention, 12(12), 3389-3396. Retrived From: http://journal.waocp.org/article_26071_267ad86d879d94f37122bbe7ed3a0edf.pdf

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.